CH668911C1 - Injizierbare gebrauchsfertige Lösungen, die ein Anthracyclinglycosid mit Antitumorwirkung enthalten. - Google Patents

Injizierbare gebrauchsfertige Lösungen, die ein Anthracyclinglycosid mit Antitumorwirkung enthalten. Download PDF

Info

Publication number
CH668911C1
CH668911C1 CH2534/86A CH253486A CH668911C1 CH 668911 C1 CH668911 C1 CH 668911C1 CH 2534/86 A CH2534/86 A CH 2534/86A CH 253486 A CH253486 A CH 253486A CH 668911 C1 CH668911 C1 CH 668911C1
Authority
CH
Switzerland
Prior art keywords
acid
injectable solutions
antitumor activity
use containing
solutions ready
Prior art date
Application number
CH2534/86A
Other languages
German (de)
English (en)
Other versions
CH668911A5 (de
Inventor
Gaetano Gatti
Diego Oldani
Giuseppe Bottoni
Carlo Confalonieri
Luciano Gambini
Ponti Roberto De
Original Assignee
Pharmacia & Upjohn S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10583216&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CH668911(C1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia & Upjohn S.P.A. filed Critical Pharmacia & Upjohn S.P.A.
Publication of CH668911A5 publication Critical patent/CH668911A5/de
Publication of CH668911C1 publication Critical patent/CH668911C1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
CH2534/86A 1985-08-02 1986-06-24 Injizierbare gebrauchsfertige Lösungen, die ein Anthracyclinglycosid mit Antitumorwirkung enthalten. CH668911C1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858519452A GB8519452D0 (en) 1985-08-02 1985-08-02 Injectable solutions

Publications (2)

Publication Number Publication Date
CH668911A5 CH668911A5 (de) 1989-02-15
CH668911C1 true CH668911C1 (de) 2000-05-31

Family

ID=10583216

Family Applications (2)

Application Number Title Priority Date Filing Date
CH02158/99A CH690490C2 (de) 1985-08-02 1986-06-24 Anthracyclinglycosidlösung.
CH2534/86A CH668911C1 (de) 1985-08-02 1986-06-24 Injizierbare gebrauchsfertige Lösungen, die ein Anthracyclinglycosid mit Antitumorwirkung enthalten.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH02158/99A CH690490C2 (de) 1985-08-02 1986-06-24 Anthracyclinglycosidlösung.

Country Status (34)

Country Link
US (1) US4946831A (nl)
JP (1) JPH0655667B2 (nl)
KR (1) KR920001773B1 (nl)
CN (1) CN1064531C (nl)
AT (1) AT397463B (nl)
BE (1) BE905202A (nl)
BG (1) BG60425B2 (nl)
CA (1) CA1291037C (nl)
CH (2) CH690490C2 (nl)
CS (1) CS277561B6 (nl)
CY (1) CY1592A (nl)
DE (1) DE3621844C2 (nl)
DK (1) DK167557B1 (nl)
ES (1) ES8801580A1 (nl)
FI (1) FI86800C (nl)
FR (1) FR2585569B1 (nl)
GB (2) GB8519452D0 (nl)
GR (1) GR861556B (nl)
HK (1) HK93990A (nl)
HU (1) HU196123B (nl)
IE (1) IE59297B1 (nl)
IL (1) IL79129A (nl)
IT (1) IT1204906B (nl)
NL (2) NL191507C (nl)
NO (1) NO170913C (nl)
NZ (1) NZ216604A (nl)
PH (1) PH22332A (nl)
PT (1) PT82865B (nl)
RU (2) RU1837883C (nl)
SE (1) SE466383C (nl)
SG (1) SG80690G (nl)
UA (1) UA29383C2 (nl)
YU (1) YU44788B (nl)
ZA (1) ZA864792B (nl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124318A (en) * 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.R.L. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5977082A (en) 1985-08-02 1999-11-02 Pharmacia & Upjohn Company Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5124317A (en) 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.P.A. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
BE1000540A5 (fr) * 1986-12-05 1989-01-24 Erba Carlo Spa Solutions injectables pretes a l'emploi contenant un agent antitumeur du type anthracycline-glucoside.
FI883337A (fi) * 1987-07-16 1989-01-17 Bristol Myers Co Icke-vattenloesningar av doxorubicinhydroklorin.
FI883338A (fi) * 1987-07-16 1989-01-17 Bristol Myers Co Vattenloesningar av doxorubicinhydroklorid.
DE3801178A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierte trockenzubereitung zytostatisch wirksamer anthracyclin-antibiotika und verfahren zu ihrer herstellung
FI895733A0 (fi) * 1988-12-05 1989-11-30 Bristol Myers Squibb Co Vattenloesningar av doxorubicin.
DE68905577T2 (de) * 1988-12-05 1993-07-01 Bristol Myers Squibb Co Doxorubicin-loesungen.
GB9200247D0 (en) * 1992-01-07 1992-02-26 Erba Carlo Spa Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation
DE19544532C2 (de) * 1995-11-29 1997-12-11 Pharma Dynamics Gmbh Verfahren zum Herstellen eines Doxorubicin-Lyophilisats
PT848009E (pt) * 1996-12-16 2000-11-30 Pharmachemie Bv Processo para a preparacao de epirubicina ou seus sais de adicao de acido a partir de daunorubicina
DE69737510T2 (de) 1996-12-30 2007-12-06 Battelle Memorial Institute, Columbus Verwendung eines unverkapselten Antikrebs-Arzneimittels zur Herstellung einer Zubereitung zur Behandlung von Neoplasmen durch Inhalation
US20090253220A1 (en) * 2003-10-28 2009-10-08 Sukanta Banerjee Absorbing Biomolecules into Gel-Shell Beads
EP1814525A2 (en) * 2005-05-11 2007-08-08 Sicor Inc. Stable lyophilized anthracycline glycosides
JP6138140B2 (ja) * 2011-10-25 2017-05-31 ネクター セラピューティクス 癌患者の治療
CN102614118B (zh) * 2012-03-15 2014-04-30 北京协和药厂 注射用盐酸表柔比星制剂的制备方法及制剂

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU33730B (en) * 1967-04-18 1978-02-28 Farmaceutici Italia Process for preparing a novel antibiotic substance and salts thereof
GB1457632A (en) * 1974-03-22 1976-12-08 Farmaceutici Italia Adriamycins
GB1500421A (en) * 1975-01-22 1978-02-08 Farmaceutici Italia Optically active anthracyclinones
US4039663A (en) * 1975-03-19 1977-08-02 Societa' Farmaceutici Italia S.P.A. Daunomycins, process for their uses and intermediates
FR2314726A1 (fr) * 1975-06-16 1977-01-14 Rhone Poulenc Ind Nouveaux derives du naphtagene, leur preparation et les compositions qui les contiennent
GB1511559A (en) * 1975-09-26 1978-05-24 Farmaceutici Italia Anthracycline glycosides
FR2397425A1 (fr) * 1977-07-11 1979-02-09 Rhone Poulenc Ind Nouveaux derives de la daunorubicine, leur preparation et les compositions qui les contiennent
DE2738656A1 (de) * 1977-08-26 1979-03-08 Microbial Chem Res Found Anthracyclinglycoside, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4177264A (en) * 1977-10-17 1979-12-04 Sri International N-benzyl anthracyclines
GB2007645B (en) * 1977-10-17 1982-05-12 Stanford Res Inst Int Benzyl anthracyclines and pharmaceutical compositions containing them
FR2430425A1 (fr) * 1978-07-07 1980-02-01 Rhone Poulenc Ind Nouveaux derives de la daunorubicine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2433027A1 (fr) * 1978-08-08 1980-03-07 Rhone Poulenc Ind Nouveau procede de preparation de derives de la doxorubicine
US4325947A (en) * 1981-05-12 1982-04-20 Farmitalia Carlo Erba S.P.A. 4-Demethoxy-4'-deoxydoxorubicin
US4438105A (en) * 1982-04-19 1984-03-20 Farmaitalia Carlo Erba S.P.A 4'-Iododerivatives of anthracycline glycosides
US4464529A (en) * 1982-07-20 1984-08-07 Sri International Analogues of morpholinyl daunorubicin and morpholinyl doxorubicin
JPS6092212A (ja) * 1983-10-26 1985-05-23 Kyowa Hakko Kogyo Co Ltd ドキソルビシン塩の製剤
BE1000540A5 (fr) * 1986-12-05 1989-01-24 Erba Carlo Spa Solutions injectables pretes a l'emploi contenant un agent antitumeur du type anthracycline-glucoside.

Also Published As

Publication number Publication date
RU1837883C (ru) 1993-08-30
IT8620917A0 (it) 1986-06-26
NL191507C (nl) 2000-02-16
SE8602743D0 (sv) 1986-06-19
NO862587D0 (no) 1986-06-26
PH22332A (en) 1988-07-29
DK167557B1 (da) 1993-11-22
FI862629A0 (fi) 1986-06-19
IE59297B1 (en) 1994-02-09
GB2178311A (en) 1987-02-11
GB2178311B (en) 1989-10-11
IT1204906B (it) 1989-03-10
PT82865A (en) 1986-07-01
ZA864792B (en) 1988-02-24
SE466383B (sv) 1992-02-10
IL79129A0 (en) 1986-09-30
AT397463B (de) 1994-04-25
IL79129A (en) 1992-03-29
NL191507B (nl) 1995-04-18
NL8601698A (nl) 1987-03-02
DK306286D0 (da) 1986-06-27
FR2585569A1 (fr) 1987-02-06
DE3621844A1 (de) 1987-03-05
CA1291037C (en) 1991-10-22
SE466383C (sv) 1996-02-19
ATA176886A (de) 1993-09-15
SG80690G (en) 1990-11-23
CN1064531C (zh) 2001-04-18
NO170913C (no) 2003-10-10
GB8614800D0 (en) 1986-07-23
GR861556B (en) 1986-10-17
FI86800B (fi) 1992-07-15
BE905202A (fr) 1987-02-02
CH668911A5 (de) 1989-02-15
SE8602743L (sv) 1987-02-03
FR2585569B1 (fr) 1990-01-19
NO170913B (no) 1992-09-21
UA29383C2 (uk) 2000-11-15
CS470886A3 (en) 1992-11-18
NO862587L (no) 1987-02-03
PT82865B (pt) 1989-01-17
NL300011I1 (nl) 2000-10-02
CS277561B6 (en) 1993-03-17
CY1592A (en) 1992-04-03
HUT42326A (en) 1987-07-28
KR920001773B1 (ko) 1992-03-02
JPH0655667B2 (ja) 1994-07-27
NZ216604A (en) 1989-10-27
US4946831A (en) 1990-08-07
CH690490C2 (de) 2000-09-29
AU598197B2 (en) 1990-06-21
RU2110263C1 (ru) 1998-05-10
BG60425B2 (bg) 1995-03-31
DE3621844C2 (de) 1994-02-17
DK306286A (da) 1987-02-03
HU196123B (en) 1988-10-28
JPS6248629A (ja) 1987-03-03
HK93990A (en) 1990-11-23
FI862629A (fi) 1987-02-03
ES8801580A1 (es) 1988-02-16
FI86800C (fi) 1999-10-28
GB8519452D0 (en) 1985-09-11
AU5885886A (en) 1987-02-12
YU44788B (en) 1991-02-28
KR870001828A (ko) 1987-03-28
ES556291A0 (es) 1988-02-16
YU103586A (en) 1988-04-30
IE861598L (en) 1987-02-02
CN86104283A (zh) 1987-01-28

Similar Documents

Publication Publication Date Title
CH668911C1 (de) Injizierbare gebrauchsfertige Lösungen, die ein Anthracyclinglycosid mit Antitumorwirkung enthalten.
DE2727150A1 (de) Praeparat zur erhoeung des ph-wertes
DE336200T1 (de) Piroxicam in waessrigen loesungen enthaltende arzneizubereitungen und verfahren zu deren herstellung.
EP0166856A1 (de) Isoliermittel
DE2506579A1 (de) Oxytetracyclinloesung zur parenteralen, peroralen und lokalen anwendung und verfahren zu deren herstellung
KR970073403A (ko) 헛개나무 추출물을 함유하는 음료 조성물과 이의 제조방법
DE2807202C2 (de) Stabile Thymosinfraktion 5 und deren Herstellung
CA2072693A1 (en) Aqueous two-component polyurethane-forming compositions and a process for their preparation
DE1492185A1 (de) Desinfektionsmittel zur Verhinderung von Karies
DE3042491A1 (de) Niedermolekulare polysaccaride aus pflanzen der compositen-familie, verfahren zu ihrer gewinnung und sie enthaltende pharmazeutische zubereitungen
EP0100447A2 (de) Kosmetisches Mittel von haarregenerierender Wirkung
CH455146A (de) Verfahren zur Herstellung von Diphtherie-Toxoiden
US4906660A (en) Wood preservative composition and method
DE2454364A1 (de) Cobalaminderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE1617500C3 (de) Konservierung von Blutplasma
DE942534C (de) Verfahren zur Herstellung von haltbaren und gut wirksamen Loesungen oder Suspensionen antibiotischer Mittel
DE932083C (de) Verfahren zur Herstellung stabiler waessriger Injektionsloesungen von 2-Methyl-5, 8-dimethoxy-furanochromon
AT210567B (de) Verfahren zum Stabilisieren einer wässerigen Lösung von Pflanzenextrakten, insbesondere herzwirksamen Pflanzenextrakten
DE537988C (de) Mittel zur Beseitigung und zur Verhuetung der Bildung von Kesselstein
DE469788C (de) Verfahren zur Herstellung haltbarer, zu Injektionszwecken geeigneter calciumhaltigerLoesungen von Theophyllin
DE637261C (de) Verfahren zur Herstellung von Chinin- bzw. Chinidinsalzen bzw. deren Loesungen
DE873118C (de) Verfahren zur Herstellung waessriger Loesungen von Methyl-Xanthinen
DE586514C (de) Verfahren zur Darstellung von Verbindungen des Coffeins mit Calcium- und Strontiumrhodanid
Takeuchi ÜBER DEN EINFLUSS VERSCHIEDENER ORGANI-SCHER VERBINDUNGEN AUF DIE UREASE
DE2920909C2 (de) Dentalpräparat zur Verhütung und Hemmung der Zahnkaries

Legal Events

Date Code Title Description
AEN Modification of the scope of the patent
PUE Assignment

Owner name: PHARMACIA S.P.A.

PFA Name/firm changed

Owner name: PHARMACIA S.P.A. TRANSFER- PHARMACIA & UPJOHN S.P.

NV New agent

Representative=s name: RITSCHER & SEIFERT PATENTANWAELTE VSP

AEN Modification of the scope of the patent

Free format text: VERZICHTSERKLAERUNG EINGEREICHT 05.08.1999VERZICHTSERKLAERUNG VEROEFFENTLICHT: 31.05.2000

SPCC Certificates - corrections

Free format text: IKS-NR. 54670/16.09.1998, 02.02.1999

NV New agent

Representative=s name: A. BRAUN, BRAUN, HERITIER, ESCHMANN AG PATENTANWAE

PUE Assignment

Owner name: PHARMACIA & UPJOHN S.P.A. TRANSFER- PHARMACIA ITAL

PL Patent ceased
SPCL Supplementary protection certificate deletion

Spc suppl protection certif: C668911/01